
ABCL vs GRFS
$ABCL vs $GRFS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABCL vs GRFS: the quick read
- ·GRFS is the larger company by market cap ($4.98B vs $4.45B).
- ·ABCL has been more active on our scanner (194 vs 23 alerts in 30 days).
- ·ABCL has the smaller float (213.6M vs 680.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·ABCL draws far more of our scanner's attention, 194 unusual-volume alerts in 30 days against 23, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 12% of each other on market cap, which makes the rest of this table the interesting part.
- ·They have diverged badly over the year: ABCL is near the top of its 52-week range while GRFS is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABCL and GRFS on TheDesperateTrader.
- Is ABCL or GRFS the better stock?
- "Better" depends on your goal, and these two are not alike. GRFS is the larger company by market cap ($4.98B vs $4.45B). ABCL has been more active on our scanner (194 vs 23 alerts in 30 days). ABCL has the smaller float (213.6M vs 680.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABCL and GRFS?
- The differences that matter: they are not in the same business - ABCL is pharmaceutical preparations and GRFS is pharmaceutical preparations; they are similar in size ($4.45B vs $4.98B); they trade at very different share prices ($13.75 vs $7.31); ABCL sits at 90% of its 52-week range against 11% for GRFS; our scanner flagged ABCL 194 times in the last 30 days against 23 for GRFS. Everything above is measured from the latest completed session and SEC filings.
- Which of ABCL and GRFS is more active right now?
- Right now ABCL is at about 0.7x its normal volume and GRFS is at about 0.7x, so ABCL is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABCL or GRFS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABCL and GRFS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.